PPARG and inflammatory bowel disease: The presence of antagonists of steroid receptors, endocrine-disrupting chemicals (EDCs), and the interaction with the glucocorticoid receptor and peroxisome-proliferator-activated receptor gamma (PPAR-γ) may play an important role in the pathogenesis of IBD through in vitro studies.